Midi Health, Inc.

Based in California, US, and founded in 2021, Midi Health Inc. operates as a provider of virtual care clinic insurance-covered solutions for hormonal changes, perimenopause, and menopause for women above 40. In February 2026, Midi Health, Inc. raised USD 100 million in series D funding led by Goodwater Capital, with participation from Foresite Capital, Impact Engine, Serena Ventures, Advance Venture Partners, Emerson Collective, GV, McKesson Ventures, and SemperVirens.

The company offers customized care plans for prescription, hormonal, and non-hormonal medications (including HRT), lifestyle coaching and wellness therapies, Supplements and botanicals, and Specialized care paths for cancer survivors and those at risk. The company also offers access to clinical care through telehealth visits, 24/7 messaging, simplified testing, and home delivery of prescriptions and supplements. Midi visits and prescriptions are covered by PPO insurance plans by insurance providers including Aetna, Anthem Blue Cross, Blue Shield, Cigna, Health Net, etc. Midi generates its revenue by charging a service fee of USD 250 for the initial visit and USD 120 to 250 for continued care visits to fine-tune the care plans.

The company plans to use the funding from February 2026 to expand care services nationwide, hire more clinicians, and invest in its technology platform to support more patients and new women’s health care lines.